Work

Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions

Year: 2019

Type: review

Source: Pharmacology & Therapeutics

DOI: 10.1016/j.pharmthera.2019.107418

Authors: Sean S. Davies, Linda S. May-Zhang, Olivier Boutaud, Venkataraman Amarnath, Annet Kirabo, David G. Harrison

Institution: Vanderbilt University

Language: English

Topic: Antioxidant Activity and Oxidative Stress

Subfield: Biochemistry

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute

Awards: Immunity, Inflammation and Hypertension, Mechanisms of Immune Activation in Hypertension, Effect of isolevuglandin in HDL structure-function in atherosclerosis, G9000044366, HDL Function in Human Disease

OpenAlex ID: W2980830845

FWCI: 0.484

Cites: 124

Cited by: 48

Related to: 10